Sung Ah Bin

Title: Innovations of Sung Ah Bin in Pharmaceutical Composition

Introduction

Sung Ah Bin is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating obesity and hyperlipaemia. His innovative approach combines a lipase inhibitor with specific oil absorbents to enhance the efficacy of oral formulations.

Latest Patents

Sung Ah Bin holds 1 patent for his invention titled "Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom." This invention provides a pharmaceutical composition that includes a lipase inhibitor and a lipophilic oil absorbent selected from hydrogenated castor oil, hydrogenated vegetable oil, glyceryl behenate, glyceryl palmitostearate, or a mixture thereof. The formulation is designed to minimize side effects such as oily spotting, fatty or oily stool, abdominal distension, and flatus. This makes it particularly advantageous for preventing or treating obesity and hyperlipaemia.

Career Highlights

Sung Ah Bin is currently associated with Amorepacific Corporation, a leading company in the beauty and health industry. His work focuses on innovative pharmaceutical solutions that align with the company's commitment to enhancing health and wellness.

Collaborations

Throughout his career, Sung Ah Bin has collaborated with talented individuals such as Jung Ju Kim and Jeong A Lee. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Sung Ah Bin's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through effective formulations. His work continues to impact the field positively, paving the way for future advancements in obesity and hyperlipaemia treatment.